Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-03393 · Session 1

What its policy is on the use of beta interferon in the treatment of multiple sclerosis.

Answered Asked by Elaine Murray Lab Lodged 16 Dec 1999

The question

To ask the Scottish Executive what its policy is on the use of beta interferon in the treatment of multiple sclerosis.

The answer

Answered by Susan Deacon on 16 Feb 2000 · 62 days after it was lodged, 48 days after it was due

In 1995, guidance about new drugs for Multiple Sclerosis and clinical advice from the Scottish Medical Advisory Committee was issued to all Health Boards. The guidance asked Health Boards, in consultation with other key interests, to develop and implement local arrangements to manage the entry of these drugs into the NHS.The guidance remains extant and its implementation is a matter for each Health Board.

In the Official Report

No contribution in the Official Report cites S1W-03393 by reference.